Reni M, Macchini M, Orsi G, Procaccio L, et al. Preoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 x 2 factorial phase 3 trial. Lancet 2025 Nov 20:S0140-6736(25)01685-X. doi: 10.1016/S0140-6736(25)01685.
PMID: 41275879